Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

256.1K

views

59

authors

13

articles

Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

256.1K

views

59

authors

13

articles

Editorial

19 February 2021

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

Jan B. Vermorken

and

Dirk Van Gestel

1,593 views

0 citations

Editors

2

Dirk Van Gestel

Service de radio-oncologie, Institut Jules Bordet, Université libre de Bruxelles

Jan Baptist Vermorken

University of Antwerp

Impact

About

Head and neck cancer is often a very complex and difficult cancer to treat, both because of the characteristics of head and neck squamous cell carcinomas (HNSCC), and the impact physically and mentally on the patient due to location and the treatment side effects. With many centers treating HNSCC, it is imperative that the quality of treatment of HNSCC is closely monitored and evaluated to ensure that patient outcomes are as positive as possible. Quality assurance of care should be irrelevant of where the cancer is diagnosed or treated. In this article collection, we will review the following areas for current best practice guidelines and possible areas of improvement:

• Diagnostic tumor markers in HNSCC in the clinical setting
• Diagnostic imaging in HNSCC
• Diagnostic pathology in HNSCC
• Best practice in surgical treatment of HNSCC
• Evidence for best practice chemotherapy treatment of HNSCC
• Best practice in Radiation treatment for HNSCC
• Follow up – how often and what should we check for?
• Supportive care in HNSCC
• The multidisciplinary team
• Impact on the guidelines – should there be a more centralised treatment plan of HNSCC?
• The statistical analysis of HNSCC treatment and outcomes

Head and neck cancer is often a very complex and difficult cancer to treat, both because of the characteristics of head and neck squamous cell carcinomas (HNSCC), and the impact physically and mentally on the patient due to location and the treatment side effects. With many centers treating HNSCC, it is imperative that the quality of treatment of HNSCC is closely monitored and evaluated to ensure that patient outcomes are as positive as possible. Quality assurance of care should be irrelevant of where the cancer is diagnosed or treated. In this article collection, we will review the following areas for current best practice guidelines and possible areas of improvement:

• Diagnostic tumor markers in HNSCC in the clinical setting
• Diagnostic imaging in HNSCC
• Diagnostic pathology in HNSCC
• Best practice in surgical treatment of HNSCC
• Evidence for best practice chemotherapy treatment of HNSCC
• Best practice in Radiation treatment for HNSCC
• Follow up – how often and what should we check for?
• Supportive care in HNSCC
• The multidisciplinary team
• Impact on the guidelines – should there be a more centralised treatment plan of HNSCC?
• The statistical analysis of HNSCC treatment and outcomes

Download ebook

Share

Editors

Dirk Van Gestel

Service de radio-oncologie, Institut Jules Bordet, Université libre de Bruxelles

Jan Baptist Vermorken

University of Antwerp

Impact

256,092 Total views

206,176 Article views

48,143 Article downloads

1,773 Topic views

Published In

Journal Thumbnail

Frontiers in Oncology

Head and Neck Cancer

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic